
Jonathan Feld
Hematologist-Oncologist · Memorial Health Care System
Credentials: · · · ·
History
- Present
Memorial Health Care System
- Until 2021
Icahn School of Medicine
- Until 2018

Research
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Journal of Clinical Investigation · 2018 · 87 citations
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Thrombosis Research · 2020 · 78 citations
Journal of Neurotrauma · 2005 · Last of 4 authors · 72 citations

22 papers

16 papers

8 papers

7 papers

6 papers · 5 as a fellow

6 papers · 6 as a fellow
- SN
6 papers
- TJ
6 papers · 5 as a fellow
Clinical trials
- 2024–2027
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)



